-
STCube begins dosing in P2 trial of nelmastobart for lung cancer
22 Jan 2026 07:03 GMT
… or metastatic non-small cell lung cancer (NSCLC).
The phase 2 study … 75 mg/m² of docetaxel. The study is currently underway … have long relied on docetaxel-based chemotherapy. Current docetaxel monotherapy in Korea …
-
Advances in Nanomedicine-Mediated Photodynamic Therapy for Lung Cancer: Challenges and Perspectives
16 Jan 2026 14:58 GMT
… personalized nanotherapeutics for lung cancer treatment.
Emerging Strategies … include DSP,73 docetaxel (DTX),76,78 … photosensitizer delivery for lung cancer treatment are comprehensively … response in immunotherapy–resistant lung tumor. Int Immunopharmacol. …
-
TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
13 Jan 2026 12:15 GMT
… datopotamab deruxtecan) compared to docetaxel in patients with TROP2 NMR … nonsquamous non-small cell lung cancer (NSCLC) without actionable … diagnostic for DATROWAY in lung cancer. The device was … About Non-Small Cell Lung Cancer
Lung cancer is the most common …
-
<![CDATA[Phase 1/2 Data Support Systemic Olvi-Vec in Lung Cancer]]>
07 Jan 2026 18:43 GMT
… with relapsed or refractory lung cancers,” said Thomas Zindrick, … path trials in progressive lung cancers, addressing a significant … second half and additional lung cancer trial readouts anticipated … checkpoint inhibitor compared to docetaxel in NSCL cancer ( …
-
Combined Use of Radioactive 125I Seeds and PD-1 Inhibitor Provides Sustained Clinical Benefit in an Elderly Patient with Advanced Non-Small Cell Lung Cancer: A Case Report
07 Jan 2026 13:23 GMT
… elderly patients with advanced lung cancer who are unsuitable … of chemotherapy consisting of docetaxel (120 mg) and … NSCLC, non-small cell lung cancer; PFS, prolonged progression-free … for a lung cancer: a narrative review. Transl Lung Cancer Res. 2021 …
-
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
05 Jan 2026 13:00 GMT
… cell lung cancer (SCLC) and progressive non-small cell lung cancer … with relapsed or refractory lung cancers,” said Thomas Zindrick … trials in progressive lung cancers, addressing a significant … checkpoint inhibitor compared to docetaxel in NSCLC. Additionally …
-
<![CDATA[Ceralasertib-Imfinzi Misses Survival End Point in Lung Cancer Trial]]>
24 Dec 2025 19:19 GMT
… docetaxel in patients with locally advanced or metastatic non-small cell lung cancer … for patients with lung cancer through our industry- … non-small cell lung cancer without actionable genomic alterations … -stage small cell lung cancer when used with …
-
AstraZeneca lung cancer drug combo misses mark in phase 3 trial
23 Dec 2025 15:14 GMT
… with advanced non-small cell lung cancer.
Ceralasertib is an oral ATR … or metastatic non-small cell lung cancer without actionable genomic alterations whose … Imfinzi or standard-of-care docetaxel.
-
AZ's ATR inhibitor ceralasertib flunks lung cancer test
22 Dec 2025 17:11 GMT
… -L1 inhibitor Imfinzi (durvalumab) or docetaxel, a standard second-line treatment … immune response of patients with lung cancer whose tumours stopped responding to … improve outcomes for patients with lung cancer through our industry-leading portfolio …
-
Recent Advances in Mitochondria-Targeted Nano-Drug Delivery Systems for Cancer Therapy
02 Feb 2026 07:56 GMT
… for combating cisplatin-resistant lung cancer. ACS Nano. … chemo-synergistic therapies against lung cancer. Regen Biomater. 2022 … with novel triphenylphosphine-docetaxel conjugate possess hierarchical … suppress metastasis in lung cancer. J Nanobiotechnology. …
About
© 1995-2026